Time for a new approach to Alzheimer’s D...

It’s the same medicine. So why does the convenient version cost so much more? 

From a Pacific island overrun by rats to hospital wards battling superbugs, why our best intentions so often backfire. 

Would you take $5,000 to be in a painful medical study? And should researchers even be allowed to ask? 

For decades, Alzheimer’s researchers have been stubbornly pursuing a single theory, but they’re starting to wonder: is this narrow focus the reason we still don’t have a cure? For more, go to http://vox.com/unexplainable It’s a great place to sign up for our newsletter, view show ... Show More

For the nearly 7 million Americans living with Alzheimer’s, progress on treatments has felt painfully slow and incremental at best…until now. Dr. Sanjay Gupta traveled the country meeting people who have slowed, prevented, and in some cases even reversed the spread of Alzheimer’s ... Show More

Over 100,000 people die from Alzheimer's Disease in the United States alone. Doctors are feverishly working to try and understand the disease in hopes of finding a cure. But the human brain holds many mysteries, and the results so far haven't been promising. Learn more about your ... Show More

Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much—yet. Learn more about your ad choices. Visit megaphone.fm/adchoices 

<pre class="syntaxhighlighter-pre" data-syntaxhighlighter-params= "brush: xml; gutter: false; theme: Midnight" data-theme= "Midnight">Do you know all there is to know beyond amyloid and tau in Alzheimer's disease? Credit available for this activity expires: 02/15/25 Earn Credit ... Show More

An overview on Dementia and why Alzheimers Research UK is here 

For decades, society has dealt with people with dementia and other forms of cognitive decline by storing them away in unstimulating, medicalized environments. But around the world, a new architectural movement is starting to challenge that old paradigm. Designing environments whe ... Show More

What are Biomarkers? And why are they useful in Alzheimer's Disease Research. 

Prof. Klaus Ebmeier is the Foundation Chair of Old Age Psychiatry. In this interview he gives his point of view on dementia, normal aging and why new treatments are not yet effective. He also explains why failure is the bread-and-butter of research and gives valuable advice to fu ... Show More